Yatharth Hospital gains 11% on debut Shares of Yatharth Hospital & Trauma Care Services Ltd on Monday jumped over 11 per cent against the issue price of Rs 300 on its first day of trade. The stock began the trade at Rs 304, a gain of 1.33 per cent, on the BSE. During… Continue reading Yatharth Hospital gains 11% on debut; Concord IPO subscribed 2.3x on day 2
Tag: Concord
SBFC IPO subscribed 6.3x on day 2, Concord Biotech IPO over half covered
SBFC offer subscribed 6.3x on second day of issue SBFC Finance’s IPO was subscribed 6.32 times on Thursday, the second day of the issue. The institutional investor portion of the IPO was subscribed 4.5 times, high networth individual portion 12.6 times and retail portion nearly 5 times. On Wednesday, SBFC had allotted shares… Continue reading SBFC IPO subscribed 6.3x on day 2, Concord Biotech IPO over half covered
Jhunjhunwala-backed Concord Biotech IPO opens today: What do analysts say?
Late investor Rakesh Jhunjhunwala-backed Concord Biotech’s (CBL) Rs 1,550 crore-initial public offer (IPO) will open for subscription today and close on August 7. The issue is entirety an offer for sale, wherein investor Helix Investment Holdings is selling its 20 per cent stake. The price band is fixed at Rs 705-741 a share. … Continue reading Jhunjhunwala-backed Concord Biotech IPO opens today: What do analysts say?
Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO
Ahmedabad-based Concord Biotech, makers of fermentation-based bulk drugs, is aiming to raise between Rs 1,475.26 crore and Rs 1,550.59 crore from an initial public offering (IPO) set to open on Friday. Rakesh Jhunjhunwala-backed Concord Biotech Ltd has fixed a price band between Rs 705 and Rs 741 a share. The public issue of… Continue reading Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO